Thursday, 29 October 2015

High hopes for targeted prostate cancer drug

Olaparib shown to slow tumours in patients with specific DNA mutations

Related items from OnMedica

Scientists find five different types of prostate cancer
Fewer but higher doses of radiotherapy good for prostate cancer
Radiotherapy implants boost chances of prostate cancer remission
Scientists unveil 'Rosetta Stone' of prostate cancer
Statins may slow prostate cancer progression in advanced disease
via OnMedica News Read More Here..

No comments:

Post a Comment